Loading...

GSK plc Peer Comparison

Metric Value Ranking
Market Cap $75.4 Billion 10/11 JNJ
$373.8B
ABBV
$341.1B
AZN
$230.8B
MRK
$216.7B
NVS
$211.3B
AMGN
$158.6B
GILD
$128.8B
SNY
$124.1B
BMY
$113.9B
GSK
$75.4B
BIIB
$19.4B
Gross Margin 74% 6/11 BIIB
100%
MRK
80%
AZN
77%
BMY
75%
NVS
75%
GSK
74%
ABBV
71%
JNJ
70%
SNY
68%
AMGN
61%
GILD
-100%
Profit Margin 15% 5/11 AMGN
33%
NVS
21%
MRK
19%
GILD
17%
GSK
15%
JNJ
12%
ABBV
11%
BIIB
11%
AZN
11%
SNY
11%
BMY
10%
EBITDA margin 33% 4/11 ABBV
49%
BMY
38%
NVS
38%
GSK
33%
JNJ
32%
AZN
30%
SNY
26%
MRK
25%
AMGN
24%
GILD
12%
BIIB
0%
Quarterly Revenue $10.1 Billion 8/11 SNY
$23.3B
JNJ
$22.5B
MRK
$16.7B
ABBV
$14.5B
AZN
$13.6B
NVS
$13.6B
BMY
$11.9B
GSK
$10.1B
AMGN
$8.5B
GILD
$7.6B
BIIB
$2.5B
Quarterly Earnings $1.5 Billion 7/11 MRK
$3.2B
AMGN
$2.8B
NVS
$2.8B
JNJ
$2.7B
SNY
$2.5B
ABBV
$1.6B
GSK
$1.5B
AZN
$1.4B
GILD
$1.3B
BMY
$1.2B
BIIB
$266.8M
Quarterly Free Cash Flow $564.1 Billion 9/11 MRK
$8.5B
BMY
$5.3B
ABBV
$5.2B
GILD
$4.5B
AMGN
$3.3B
NVS
$3.1B
AZN
$2.0B
BIIB
$800.2M
GSK
$564.1M
JNJ
-$0
SNY
-$553.8M
Trailing 4 Quarters Revenue $40.3 Billion 8/11 JNJ
$87.7B
SNY
$74.6B
MRK
$63.2B
ABBV
$55.5B
AZN
$51.2B
NVS
$50.7B
BMY
$47.4B
GSK
$40.3B
AMGN
$32.5B
GILD
$28.3B
BIIB
$9.6B
Trailing 4 Quarters Earnings $5.2 Billion 6/11 SNY
$23.3B
JNJ
$22.5B
MRK
$16.7B
ABBV
$14.5B
AZN
$13.6B
NVS
$13.6B
BMY
$11.9B
GSK
$10.1B
AMGN
$8.5B
GILD
$7.6B
BIIB
$2.5B
Quarterly Earnings Growth -28% 6/11 AMGN
64%
SNY
57%
BIIB
7%
AZN
4%
ABBV
-12%
GSK
-28%
MRK
-33%
BMY
-37%
GILD
-43%
NVS
-67%
JNJ
-90%
Annual Earnings Growth -34% 7/11 BIIB
3495%
MRK
192%
SNY
6%
AZN
-5%
NVS
-13%
AMGN
-28%
GSK
-34%
ABBV
-35%
JNJ
-65%
GILD
-98%
BMY
-189%
Quarterly Revenue Growth 10% 5/11 SNY
99%
AMGN
23%
AZN
18%
NVS
15%
GSK
10%
BMY
8%
GILD
7%
JNJ
5%
ABBV
4%
MRK
4%
BIIB
3%
Annual Revenue Growth 12% 3/11 SNY
57%
AMGN
17%
GSK
12%
AZN
12%
BMY
6%
NVS
6%
GILD
5%
MRK
3%
ABBV
0%
BIIB
-4%
JNJ
-10%
Cash On Hand $3.8 Billion 8/11 MRK
$14.6B
NVS
$11.5B
AMGN
$9.0B
BMY
$7.9B
SNY
$7.5B
ABBV
$7.3B
AZN
$4.8B
GSK
$3.8B
BIIB
$2.4B
GILD
-$0
JNJ
-$0
Short Term Debt $4.3 Billion 4/11 ABBV
$12.6B
SNY
$10.5B
NVS
$8.3B
GSK
$4.3B
AMGN
$3.5B
MRK
$3.1B
AZN
$1.6B
BMY
$1.1B
GILD
-$0
JNJ
-$0
BIIB
-$0
Long Term Debt $17.4 Billion 7/11 ABBV
$58.5B
AMGN
$56.9B
BMY
$48.7B
MRK
$35.0B
AZN
$30.0B
NVS
$22.9B
GSK
$17.4B
SNY
$13.7B
BIIB
$4.9B
GILD
$0
JNJ
$0
PE 14.58 8/11 GILD
1021.84
ABBV
66.51
AMGN
37.50
AZN
35.54
JNJ
25.46
MRK
17.84
NVS
17.70
GSK
14.58
SNY
14.35
BIIB
11.91
BMY
-1.00
PS 1.46 11/11 ABBV
6.14
AMGN
4.88
GILD
4.55
AZN
4.51
JNJ
4.26
NVS
4.17
MRK
3.43
BMY
2.40
BIIB
2.03
SNY
1.51
GSK
1.46
PB 4.27 8/11 ABBV
56.18
AMGN
21.07
BMY
6.62
AZN
5.66
JNJ
5.23
MRK
4.86
NVS
4.79
GSK
4.27
GILD
3.01
SNY
1.55
BIIB
1.11
PC 19.86 3/11 AZN
48.12
ABBV
47.00
GSK
19.86
NVS
18.44
AMGN
17.60
SNY
16.62
MRK
14.85
BMY
14.43
BIIB
8.19
GILD
-1.00
JNJ
-1.00
Liabilities to Equity 3.08 4/11 ABBV
22.77
AMGN
11.07
BMY
4.46
GSK
3.08
MRK
1.64
AZN
1.57
NVS
1.32
SNY
0.78
BIIB
0.61
GILD
0.00
JNJ
-1.00
ROA 0.09 3/11 NVS
12%
MRK
10%
GSK
9%
SNY
7%
BIIB
6%
AZN
6%
AMGN
5%
ABBV
4%
GILD
0%
BMY
-8%
JNJ
-100%
ROE 0.36 3/11 ABBV
85%
AMGN
56%
GSK
36%
MRK
27%
NVS
27%
JNJ
21%
AZN
16%
SNY
12%
BIIB
9%
BMY
-42%
GILD
-100%
Current Ratio 1.31 7/11 GILD
4.65
BIIB
2.65
SNY
2.29
NVS
1.76
AZN
1.64
MRK
1.61
GSK
1.31
BMY
1.22
AMGN
1.09
ABBV
1.04
JNJ
0.00
Quick Ratio 0.07 9/11 GILD
1021.84
ABBV
66.51
AMGN
37.50
AZN
35.54
JNJ
25.46
MRK
17.84
NVS
17.70
GSK
14.58
SNY
14.35
BIIB
11.91
BMY
-1.00
Long Term Debt to Equity 0.94 4/11 ABBV}
9.70
AMGN}
7.55
BMY}
2.84
GSK}
0.94
MRK}
0.79
AZN}
0.74
NVS}
0.52
BIIB}
0.28
SNY}
0.17
JNJ}
0.00
GILD}
-1.00
Debt to Equity 1.18 4/11 ABBV
11.78
AMGN
8.02
BMY
2.90
GSK
1.18
MRK
0.86
AZN
0.78
NVS
0.71
SNY
0.33
BIIB
0.28
JNJ
0.00
GILD
-1.00
Burn Rate -24.84 10/11 NVS
63.53
AZN
29.40
AMGN
27.29
SNY
16.54
BMY
7.85
ABBV
1.85
GILD
0.00
JNJ
0.00
MRK
-15.04
GSK
-24.84
BIIB
-33.20
Cash to Cap 0.05 6/11 BIIB
0.12
BMY
0.07
MRK
0.07
AMGN
0.06
SNY
0.06
GSK
0.05
NVS
0.05
ABBV
0.02
AZN
0.02
GILD
0.00
JNJ
0.00
CCR 0.38 9/11 BMY
4.35
GILD
3.63
ABBV
3.33
BIIB
3.00
MRK
2.69
AZN
1.42
AMGN
1.17
NVS
1.09
GSK
0.38
JNJ
0.00
SNY
-0.22
EV to EBITDA 42.17 8/11 GILD}
144.99
AMGN}
102.58
AZN}
62.79
MRK}
58.74
ABBV}
57.49
JNJ}
52.65
NVS}
44.55
GSK}
42.17
BMY}
34.02
SNY}
28.23
BIIB}
-1.00
EV to Revenue 2.74 9/11 ABBV
7.29
AMGN
6.46
AZN
5.03
NVS
4.56
GILD
4.55
JNJ
4.26
MRK
3.80
BMY
3.28
GSK
2.74
SNY
2.06
BIIB
-1.00